Kidney Protection in Type 1 Diabetes
Despite no new drugs approved for CKD in type 1 diabetes in the past decade, urgent action is needed to develop new therapies and improve outcomes for this population.
This paper discusses the need for new therapies in type 1 diabetes, a population with limited treatment options. The authors highlight the importance of developing new treatments to improve outcomes for individuals with type 1 diabetes. Research on kidney protection in type 1 diabetes is crucial to address the growing burden of CKD in this population. The authors reference recent studies and data to emphasize the need for urgent action to develop new therapies and improve outcomes for individuals with type 1 diabetes.